GitLab Inc
NASDAQ:GTLB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
GitLab Inc
NASDAQ:GTLB
|
US |
|
Protagonist Therapeutics Inc
NASDAQ:PTGX
|
US |
|
A
|
Aeluma Inc
OTC:ALMU
|
US |
|
Davide Campari Milano NV
MIL:CPR
|
IT |
|
F
|
First Watch Restaurant Group Inc
NASDAQ:FWRG
|
US |
|
M
|
Myriad Genetics Inc
LSE:0K3W
|
US |
|
U
|
Unisys Corp
SIX:UIS
|
US |
|
UPM-Kymmene Oyj
OMXH:UPM
|
FI |
|
Guotai Junan Securities Co Ltd
SSE:601211
|
CN |
|
B
|
Boyd Gaming Corp
DUS:BO5
|
US |
|
S
|
Synaptics Inc
SWB:SJN
|
US |
|
C
|
Chongqing Water Group Co Ltd
SSE:601158
|
CN |
Wall St Price Targets
GTLB Price Targets Summary
GitLab Inc
According to Wall Street analysts, the average 1-year price target for
GTLB is 33.1 USD with a low forecast of 24.24 USD and a high forecast of 63 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GTLB's stock price target?
Price Target
33.1
USD
According to Wall Street analysts, the average 1-year price target for
GTLB is 33.1 USD with a low forecast of 24.24 USD and a high forecast of 63 USD.
What is the Revenue forecast for GitLab Inc?
Projected CAGR
14%
Over the last 5 years, the compound annual growth rate for Revenue has been 44%. The projected CAGR for the next 8 years is 14%.